Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael Andrew Chambers files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ian Michael Estepan - $294K in SRPT purchases and sales in the last 12 months
- Stephen Mayo - $123K in SRPT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Andrew Chambers?
Michael Andrew Chambers is a corporate insider of Sarepta Therapeutics, Inc. (SRPT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael Andrew Chambers last file a Form 4?
The most recent primary Form 4 on record is dated 6 June 2026, one of 2 filings going back to 2025.
